awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30803684-94F18A4A-C178-4DE3-B829-5CE2E4C9F86E
Q30803684-94F18A4A-C178-4DE3-B829-5CE2E4C9F86E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30803684-94F18A4A-C178-4DE3-B829-5CE2E4C9F86E
Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.
P2860
Q30803684-94F18A4A-C178-4DE3-B829-5CE2E4C9F86E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30803684-94F18A4A-C178-4DE3-B829-5CE2E4C9F86E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
351ed8d0e791135a56e0e16c2fb4be1483557b7e
P2860
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c.